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Abstract
Background: The incidence of cervical cancer in Paraguay is among the highest in the world, with the human
papillomavirus (HPV) being a necessary factor for cervical cancer. Knowledge about HPV infection among
indigenous women is limited. This cross-sectional study analyzed the frequency of HPV and other genital infections
in indigenous Paraguayan women of the Department of Presidente Hayes.
Methods: This study included 181 sexually active women without cervical lesions. They belonged to the following
ethnicities: Maká (n = 40); Nivaclé (n = 23); Sanapaná (n = 33); Enxet Sur (n = 51) and Toba-Qom (n = 34). The
detection of HPV and other gynecological infectious microorganisms was performed by either molecular methods
(for Mycoplasma hominis, Ureaplasma urealyticum, Chlamydia trachomatis), gram staining and/or culture (for
Gardnerella vaginalis, Candida sp, Trichomonas vaginalis, Neisseria gonorrhoeae), serological methods (for
Treponema pallidum, human immunodeficiency virus [HIV]) or cytology (cervical inflammation).
Results: A high prevalence (41.4%) of women positive for at least one sexually transmitted infection (STI) was found
(23.2% any-type HPV, 11.6% T pallidum, 10.5% T vaginalis, 9.9% C trachomatis and 0.6% HIV) with 12.2% having more
than one STI. HPV infection was the most frequent, with 16.1% of women positive for high-risk HPV types. There
was a statistically significant association observed between any-type HPV and C trachomatis (p = 0.004), which indi-
cates that the detection of one of these agents should suggest the presence of the other. There was no association
between any-type HPV and other genital infections or cervical inflammation, suggesting that other mechanism
could exist to favor infection with the virus.
Conclusion: This multidisciplinary work suggests that STIs are frequent, making it necessary to implement control
measures and improve diagnosis in order to increase the number of cases detected, especially in populations with
poor access to health centers.
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Background
Cervical cancer is second globally as a malignant tumor
among women and accounts for 9.8% of all cancer cases.
According to 2008 data, Paraguay ranks seventh in the
incidence of cervical cancer in Latin America, with an
incidence rate of 35.0/100,000 women-years and a mor-
tality rate of 16.6/100,000 women-years [1].
Human papillomavirus (HPV) is the causative agent of
cervical intra-epithelial neoplasia (CIN) and cervical can-
cer and is the most common sexually transmitted viral in-
fection worldwide [2]. There are more than 100 types of
HPV, including 40 types that exclusively infect the cervical
mucosa. Based on the known epidemiological associations
with cervical cancer, HPV is categorized as high-risk HPV
(HR-HPV), as low-risk HPV (LR-HPV) or in other unclas-
sified groups [3].
However, there is evidence on the role of other
sexually transmitted agents as co-factors for the devel-
opment of cervical cancer in HPV-positive women.
Chlamydia trachomatis and human immunodeficiency
virus (HIV) are the two most studied of these agents
[4-7]. It was suggested that the increased risk of cervical
cancer in women co-infected with C trachomatis is due,
in part, to an inflammatory response associated with
free radical generation and the development of genetic
instability [6]. Other organisms such as Gardnerella sp,
Candida sp, Trichomonas sp, Mycoplasma hominis,
Ureaplasma urealyticum and Treponema pallidum have
also been associated with cervical inflammatory pro-
cesses, a situation that may facilitate the entrance of
HPV [8,9].
Molecular methods, such as polymerase chain reaction
(PCR), have permitted the detection of infectious agents
from the genital tract that are difficult or impossible to
isolate by conventional techniques, allowing for a gain in
sensitivity and specificity. This is true for HPV as well as
other infectious agents such as Ureaplasma parvum, U
urealyticum, C trachomatis, M hominis and Mycoplasma
genitalium [10-12].
According to data from the Directorate General of
Surveys, Statistics and Census of 2008, ethnic popula-
tions of Paraguay have a fertility rate of 6.3 children per
woman and a low education level, with 38.9% of the
population over 14 years of age being illiterate. Further-
more, most indigenous communities have difficulty in
accessing health care. All these factors, in conjunction
with chronic HPV infection, could favor the develop-
ment of cervical cancer [13,14].
The Department of Presidente Hayes in Paraguay has
the largest indigenous population, representing 23% of the
total population with 108,600 inhabitants, based on data
from the Directorate General of Surveys, Statistics and
Census of 2008 [13]. Only a few studies on the detection
of sexually transmitted infections (STIs) (e.g., HIV, syphilis
and hepatitis B virus) have been conducted in Paraguayan
indigenous women [15,16].
The aim of this study was to determine for the first
time the frequency of HPV infection and other genital
infections among indigenous women from Paraguay.
Methods
This analytical cross-sectional study included 181 indigen-
ous women, sexually active, not pregnant and with no
medical or surgical treatment during the study period, be-
longing to the Department of Presidente Hayes, Paraguay.
While there are national centers for primary health
care offering cytology (Papanicolaou [Pap] smear) at no
cost, most indigenous women cannot access these cen-
ters. In this context and in order to get closer to these
women for the opportunity to determine their status re-
garding STIs, the working group contacted the author-
ities of the Regional Hospital of Villa Hayes, which is
located near the areas inhabited by indigenous commu-
nities included in this study. They coordinated three
medical visits to each indigenous community. The visits
were organized as follows: the first was to contact the
Cacique and indigenous community leaders to explain
the objectives of the study and obtain approval for the
study; the second was to inform women of the objec-
tives of the study, the study conditions and require-
ments, the potential benefits to be gained and to invite
them to participate. Finally, the third visit was made to
obtain cervical samples from those women who had
agreed to participate.
Visits were made to women who belonged to the
Qemkuket community of ethnic Maká; the Novoctas
community of ethnic Nivacle; the Laguna Pato Complex
of ethnic Sanapaná; the Maxhawaya and Espinillo commu-
nities of ethnic Enxet South; and finally the Rio Verde and
Toba-Qom communities belonging to ethnic Toba-Qom.
The study protocol (P11/2010) was approved by the
Ethics Committee of the Institute for Research in Health
Sciences of the National University of Asunción. All
women signed an informed consent written in Spanish
prior to the sampling of biological material and the ap-
plication of a questionnaire to collect data related to
socio-demographic and sexual characteristics of indigen-
ous women. In the case of indigenous women who did
not speak Spanish, informed consent was translated to
her language by a community member. Furthermore, in
the case of women under 18 years old, informed consent
was signed by the parent or guardian. The results of the
study were presented at the local hospital (Regional
Hospital of Villa Hayes), whose area of influence are the
indigenous localities included in this study, for monitor-
ing and treatment. All women with treatable infections
received appropriate treatment. In particular, in the case
of HPV studies, the following criteria were adopted for
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clinical management: women who tested positive for
HPV but had negative cytology result would be followed
with a cytology control in a year; and women who tested
positive for both HPV and cytology would be referred
for colposcopy.
The study material collected included:
– A blood sample for serology (syphilis screening and
detection of HIV).
– A sample of vaginal secretions for Gardnerella
vaginalis, Candida sp and Trichomonas vaginalis
analysis.
– Two endocervical brushes, one for the molecular
detection of HPV, M hominis, C trachomatis and U
urealyticum and the other for cervical cytology
screening.
– A cervical swab for detection of Neisseria
gonorrhoeae by isolation in Thayer-Martin medium.
Collection of blood samples, vaginal secretions and
endocervical brushes was made by medical doctors or
nurses at the Health Post of the indigenous communities
or in cases where there were no Health Posts, at the home
of the family. Any biological material collected was appro-
priately transported and stored until processing.
Cytology (Papanicolaou [Pap] smear)
Cervical brushing was performed by a trained gynecologist
and placed in a slide correctly identified, which was re-
ferred to the Health Sciences Research Institute (IICS),
National University of Asunción (UNA) for analysis. The
interpretation of the findings and categorization of results
were reported according to the Bethesda System 2001 [17].
HPV genotyping by PCR-Reverse Line Blot hybridization
(RLB)
Cervical cells were collected using a conical brush, which
was placed into a tube with a preservative solution (DNA
collection device Hybrid Capture 2, Digene Corporation,
Gaithersburg, USA). The sample was subsequently stored
at −70°C until processing.
The DNA extraction from cervical samples was per-
formed by the method described by Mendoza et al. [18].
The quality of the extracted DNA was verified by PCR
amplification of a 268 bp fragment of the gene for β-
globin gene using the primers PC04 and GH20 [19].
The viral genome detection was performed by a gen-
eric PCR using consensus primers PGMY 09/11, which
amplify a 450 bp fragment of L1 viral gene [20]. HPV
genotyping was performed by the RLB (CHUV) method,
as previously described by Estrade et al. [20], using the
type-specific oligoprobes corresponding to 37 HPV types
(HPVs 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66,
68, 6, 11, 26, 34, 40, 42, 43, 44, 53, 54, 55, 57, 61, 70, 71
[CP8061], 72, 73, 81 [CP8304], 82/MM4, 82/IS39, 83
[MM7], 84 [MM8] and CP6108). The classification of
HPV as high-risk types was performed according to
Muñoz et al. [3]; HPV 16, 18, 31, 33, 35, 39, 45, 51, 52,
56, 58, 59, 68, 73 and 82 were included in this group. In
addition, HPV 26, 53 and 66 were included as probable
HR-HPV.
Detection of other genital infections
Vaginal secretions (G vaginalis, Candida sp. and T vagi-
nalis) and endocervical swab samples (for N gonor-
rhoeae) were taken, placed in Stuart transport medium
and sent to the IICS Microbiology Laboratory, where a
smear, Gram stain and culture on appropriate media
were performed [21].
Syphilis was detected from a blood sample using the
serological test Venereal Disease Research Laboratory
(VDRL test, Wiener lab, Rosario, Argentina). All VDRL-
positive samples were confirmed by fluorescent T palli-
dum antibodies (FTA-ABS, slide Trepospot BioMerieux,
Marcy l'Etoile, Francia; conjugated IgG BioMeriex, Marcy
l'Etoile, Francia).
HIV was detected using a fourth generation enzyme im-
munoassay (ELISA), used as per the manufacturer’s in-
structions, for determination of antibodies to HIV types 1
and 2 and the p24 antigen of HIV-1 in human serum and
plasma (DIA.PRO Diagnostic Bioprobes SRL, Milán, Italy).
HIV-positive samples were submitted for a second ELISA
and subsequently confirmed by RecomLine HIV-1 and
HIV-2 IgG (Mikrogen Diagnostik, Neuried, Germany).
M hominis, C trachomatis, U urealyticum were detected
from DNA extracted from genital samples and were ana-
lyzed by multiplex-PCR according to the protocol de-
scribed by Golshani et al. [11].
Statistical analysis
The sample size calculation to determine the frequency
of HPV was made using an estimated prevalence of 30%
with a 95% confidence interval, a width of 7% and a total
population of indigenous women of the Presidente Hayes
Department over 10 years of age of 9,492 [22]. The re-
quired sample size was 162 women. Considering the Dir-
ectorate General of Surveys, Statistics and Census, which
showed that the different ethnic groups in this study had
common features, such as a high fertility rate (6.3 children
per woman) and a low education level (a mean of 2.2 years
of school), we decided to make a single sample size calcu-
lation including women of different ethnicities [13,22].
The analysis was performed using descriptive and analyt-
ical statistics. The association between proportions was
assessed by chi-square analysis using Epi Info™ 7.1.1.14
(Centers for Disease Control and Prevention, Atlanta,
USA). For all data analyses conducted, p values < 0.05 were
considered statistically significant.
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Results
Of the 181 women enrolled, 40 women belonged to the
Qemkuket community of ethnic Maká; 23 to the Novoctas
community (15 Marcelo Cue, 8 Duarte Cue) of ethnic
Nivacle; 33 to the Laguna Pato Complex (9 Lolaico”i, 13
Lolaico guasú, 3 Brillante, 7 Laguna Pato, 1 Salado) of
ethnic Sanapaná; 28 to Maxhawaya (5 Monte Alto, 23
Maxhawaya) and 23 to Espinillo (13 Espinillo, 10 Pozo
Colorado), both communities of ethnic Enxet South;
and 16 women of Rio Verde and 18 women of Toba-
Qom belonging to ethnic Toba-Qom. Figure 1 shows
the map of Presidente Hayes Department, including the
study participants’ communities. The communities vis-
ited ranged between 30 and 434 km in distance from
Asunción, the capital of Paraguay.
The demographic characteristics, as well as the repro-
ductive and sexual history of the 181 women included in
this study, are shown in Table 1. The median age was
30 years (interquartile range, 23–41), with 47% (85/181
women) being younger than 30. The observed illiteracy
rate was 39%, with a median of 2 years of school. A high
percentage of women (60%) used hormonal contracep-
tives. Notably, 71.8% of indigenous women participants
underwent a Pap smear for the first time.
A high frequency of STIs was detected, 41.4% (95% CI
34.2%-49%), primarily as HPV (any type), syphilis, C tracho-
matis, T vaginalis and HIV. In 12.2% (95% CI 7.8%-17.8%)
of the women studied, more than one STI was detected,
although any-type HPV infection was the most frequent.
Table 2 shows the frequency of genital infections.
The prevalence of any-type HPV DNA was 23.2%
(95% CI 17.3%-30%) and was 16.1% (95% CI 11.1%-22.3%)
among HR-HPV positive women. A higher frequency of
HR-HPV was detected in women in the age ranges of 13
Figure 1 Map of Presidente Hayes Department, Paraguay.
Participating communities are marked by triangles; A. Rio Verde
(52 km from Asuncion); B. Tobaqom (51 km from Asuncion);
C. Quemkuket (30 km from Asuncion); D. Maxhawaya (326 km from
Asuncion); E. Laguna Pato Complex (320 Km from Asuncion); FyG.
Novoctas (434 km from Asuncion) and H. Espinillo (297 km
from Asuncion).
Table 1 Socio-demographic and sexual characteristics of
indigenous women
Characteristics Total (n = 181 women)
Age (years)
Median (Interquartile range) 30 (23–41)
Education (years)
Median (Interquartile range) 2 (0–4)
Illiterate n (%) 73 (40.3)
Elementary school n (%) 95 (52.5)
High school n (%) 13 (7.2)
Age at 1st sexual intercourse (years)
Median (Interquartile range) 16 (13–19)
≤16 n (%) 105 (58.0)
> 16 n (%) 76 (42.0)
n sexual partners
Median (Interquartile range) 1 (1–2)
1 n (%) 107 (59.1)
2-3 n (%) 62 (34.2)
≥4 n (%) 12 (6.6)
Pregnancies
Yes n (%) 165 (91.1)
No n (%) 16 (8.8)
n pregnancies
Median (Interquartile range) 3 (2–5)
1-3 n (%) 85 (51.1)
4-6 n (%) 49 (29.7)
>6 n (%) 31 (17.1)
Oral contraceptive use
Yes n (%) 107 (59.1)
No n (%) 74 (40.9)
Smoking
Yes n (%) 39 (21.5)
No n (%) 142 (78.5)
Previous Cytology
Yes n (%) 51 (28.2)
No n (%) 130 (71.8)
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to 29 years (18.8%) and over 49 years (23.1%). Table 3
shows the frequency of HR-HPV in relation to age.
According to cytological diagnosis, all 181 women were
negative for cervical lesions; however, 13.8% (95% CI
9.1%-19.7%) of women presented with cervical inflamma-
tion. There was no significant association observed be-
tween the presence of inflammation and any-type HPV
infection.
In addition, there was a statistically significant associ-
ation between the concomitant presence of any-type
HPV and C trachomatis infection (p = 0.004). No signifi-
cant association was found between HPV and M homi-
nis, U urealyticum, T vaginalis, G vaginalis or Candida
sp infection. Table 4 shows the distribution of genital
infections and cervical inflammation according to HPV
results.
Discussion
There are a few epidemiological studies of HPV detec-
tion and probable co-factors associated with the acquisi-
tion of viral infection in indigenous populations in
South America [23-27]. This is the first study for the de-
tection of HPV, C trachomatis and other sexually trans-
mitted agents in the indigenous population of Paraguay,
and it may serve as a precedent for future epidemio-
logical investigations of STIs.
Any-type HPV and HR-HPV were detected in 23.2%
and 16.1% of the total women studied, respectively. These
results are comparable to those found by Mendoza et al.
[18]. That series found a 20.8% prevalence of any-type
HPV and 13.5% for HR-HPV in Caucasian women with
negative cytology. However, these results are lower than
the frequency detected in studies performed with indigen-
ous women from Misiones (64% any-type HPV and 59%
HR-HPV) and Jujuy (52% any-type HPV), Argentina
and indigenous from the Brazilian Amazon (42.85%
any-type HPV) and Venezuelan Amazon (57% any-type
HPV) [23-25,27].
This disparity may be due to dissimilarity between the
demographic characteristics and sexual behaviors, among
others, of the participants, which could differentiate the
risk of acquisition of the viral infection in these popula-
tions. The indigenous women analyzed in this study had
an average age of 30 years and an average of 3 pregnancies,
and most of them (59%) declared only one sexual partner.
In contrast, in the population analyzed by Tonon et al.
[23], the indigenous women participants had a median age
of 15 years, and 61% of them were less than 30 years. It is
well known that HPV infection is age dependent, being
most common in women younger than 25 years old [28].
This could partly explain the lower prevalence of HPV ob-
served in the present work. In addition, populations of
indigenous women from Argentina and Brazil presented
with other features, such as a high frequency of polygamy
and of pregnancies among other co-factors. Although
monogamy by women is not enough for limiting the risk
of STIs, because the partner’s behavior is also crucial, pol-
ygamy would favor the acquisition of an STI [23-25,27].
However, the prevalence of any-type HPV detected in
this study (23.2%) was higher than the 13.2% (95% CI
12.7%-13.7%) observed in a meta-analysis including 17,500
urban women from South America with normal cytology
[28]. This difference could be due to geographical parame-
ters, ethnicity, sexual behavior and the techniques used for
the HPV detection, among other factors. It should be
taken into account that the detection of HPV infection in
young women (primarily <30 years old) is mostly at the
expense of transient infections that clear rapidly [29]; the
relatively increased HPV prevalence detected in the indi-
genous women with a median age of 30 years could have
more chance of being associated with persistent infections,
Table 2 Frequency of genital infections detected in
indigenous women of the Department of Presidente
Hayes, Paraguay
n (%) 95% CI
n Total 181 (100)
HPV 42 (23.2) 17.3-30.0
HR-HPV* 29 (16.1) 11.1-22.3
Probable HR-HPV** 7 (3.9) 1.6-7.8
Syphilis (VDRL & IgG***) 21 (11.6) 7.3-17.2
Trichomonas vaginalis 19 (10.5) 6.4-15.9
Chlamydia trachomatis 18 (9.9) 6.0-15.3
HIV 1 (0.6) 0-3.0
STI total**** 75 (41.4) 34.2-49
More than 1 STIs 22 (12.2) 7.8-17.8
Other genital infection
Gardnerella vaginalis 83 (45.9) 38.4-53.4
Mycoplasma hominis 56 (30.9) 24.3-38.2
Ureaplasma urealyticum 37 (20.4) 14.8-27.1
Cándida sp 13 (7.2) 3.9-12.0
CI: Confidence Interval; HPV: human papillomavirus; HR-HPV: high-risk onco-
genic HPV; HIV: human immunodeficiency virus; STI: sexually transmitted infec-
tion (HPV, VDRL, Trichomonas vaginalis, Chlamydia trachomatis, HIV); VDRL:
Venereal Disease Research Laboratory.
*Frequency of positive samples for at least one type of HR-HPV.
**Frequency of positive samples for at least one type of probable HR-HPV.
***Confirmed by Immunoglobulin G (IgG).
**** Frequency of women with at least one sexually transmitted infection.
Table 3 Frequency of HR-HPV by age of indigenous
women of the Department of Presidente Hayes, Paraguay
Age (years)
<30 30-39 40-49 ≥50
n Total 85 45 25 26
Frequency of HR-HPV n (%) 16 (18.8) 5 (11.1) 2 (8.0) 6 (23.1)
HR-HPV: high-risk oncogenic human papillomavirus.
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which might represent a risk factor for cervical cancer de-
velopment in this population.
Another important finding in this study was that all
181 women were negative for cervical lesions. These
data are consistent with those provided by the Central
Laboratory of Cytodiagnosis of the Ministry of Public
Health for 2001 and 2006, which detected a frequency
of abnormal Pap tests of 0.5% and 1.1%, respectively, in
urban Paraguayan women [30]. However, it should be
noted that cytology is a subjective and poorly reprodu-
cible test with limited sensitivity that requires regular
repetition to achieve the desired efficacy [31]. Further-
more, Sankaranarayanan et al. [32] observed a signifi-
cantly low sensitivity of cytology in women aged 25 to
39 years (p < 0.001); this range of age includes most of
the women in the present study. In this context, it can-
not be ruled out that the some cervical abnormalities
could have been missed.
A high frequency of STIs (41.4%) was detected, with
12.2% presenting with more than one sexually transmitted
organism. Despite the fact that most indigenous women
(59.1%) declared only one sexual partner, their male part-
ners are probably polygamous, which represents a higher
risk of acquiring an STI, in an unfavorable scenario of dif-
ficult access for infections treatment.
The frequency of STIs detected were higher than that
observed in the study by Oliveira et al. [9], which, in
northern Brazil, detected a frequency of 19.6% (95% CI
16.5%-23.2%) in Caucasian immunocompetent women
with at least one STI (HPV, C trachomatis, N gonorrhoeae,
T vaginalis or syphilis). These present results are also lower
than those reported by Menendez et al. [33], who detected
a frequency of 70% (95% CI 64%-76%) in women from
rural areas of Mozambique, Africa with at least one STI,
including HIV-positive women. Although in the present
study cervical lesions were not detected, the results suggest
that STIs are frequent in indigenous women and, therefore,
these infections should be checked periodically as they are
considered risk factors for the development of cervical can-
cer and other pathologies.
The significant association found in this study between
any-type HPV and C trachomatis is in agreement with
Smith et al. [34], who observed that among HPV DNA-
positive cases and controls, the risk of invasive cervical
cancer was almost twice as high in C trachomatis sero-
positive than in seronegative women (odds ratio [OR] =
1.8; 95% CI 1.2-2.7), after adjustment for age, center, oral
contraceptive use, history of Pap smears, number of full-
term pregnancies and herpes simplex virus 2 seropositiv-
ity. In addition, da Silva Barros et al. [7] suggested that
C trachomatis seropositivity seemed to be associated
with the severity of cervical neoplasia in women infected
with HPV, principally when HPV types 16 and 18 were in-
volved. Therefore, it may be important to screen women
infected with HPV for co-infection with C trachomatis,
bearing in mind that this association may have synergistic
pathological effects.
It is suggested that the increased risk of developing
cervical cancer in women co-infected with microorgan-
isms mentioned above is the result of an inflammatory
response [6]; but the mechanism by which these co-
infections favor the development of cervical cancer is not
yet clear [35]. In the present study, an association between
cervical inflammation and HPV was not detected, which
suggests that other mechanism may be involved.
It was notable that no women positive for N gonor-
rhoeae were identified. This may be due to the method-
ology of the culture used, which has some disadvantages
especially in settings where long distance travel makes
maintenance of conditions for the optimal performance
of the culture difficult [36]. These results suggest that test-
ing and diagnosis of N gonorrhoeae must be improved in
Table 4 Frequency of genital infections and cervical inflammation according to any human papillomavirus results of
indigenous women
Variables Frequency of genital infections P-value
HPV positive women (n = 42) HPV negative women (n = 139)
n (%) 95% CI n (%) 95% IC
Gardnerella vaginalis 20 (47.6) 32.0-63.6 63 (45.3) 36.9-54.0 p = 0.974
Mycoplasma hominis 16 (38.1) 23.6-54.4 40 (28.8) 21.4-37.1 p = 0.254
Ureaplasma urealyticum 11 (26.2) 13.9-42.0 26 (18.7) 12.6-16.2 p = 0.292
Syphilis (VDRL & IgG*) 3 (7.1) 1.5-19.5 18 (12.9) 7.9-19.7 p = 0.304
Trichomonas vaginalis 5 (11.9) 4.0-25.6 14 (10.1) 5.6-16.3 p = 0.734
Chlamydia trachomatis 9 (21.4) 10.3-36.8 9 (6.5) 3.0-11.9 p = 0.004
Cándida sp 2 (4.8) 0.6-16.2 11 (7.9) 4.0-13.7 p = 0.489
HIV - 1 (0.7) 0-3.9 -
Cervical inflammation 5 (11.9) 4.0-25.6 20 (14.4) 9.0-21.3 P = 0.683
HPV: human papillomavirus, CI: Confidence Interval, VDRL: Venereal Disease Research Laboratory.*Confirmed by IgG.
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order to enhance the number of cases detected, especially
in populations with a high frequency of other STIs and
with poor access to health centers.
Conclusions
Finally, despite not having detected cervical lesions in
the indigenous women included in this study, a high fre-
quency of HPV and other STIs was observed. In addition,
this work suggests that in HPV-positive women, the pres-
ence of C trachomatis should be evaluated. These data
confirm that screening for genital infections may be im-
portant to reveal the simultaneous presence of different
STIs and facilitate the adoption of measures for treatment,
monitoring and disease prevention. At the same time,
this multicenter study helped to implement new mo-
lecular techniques for detection of these infections in
the Paraguayan laboratory (IICS-UNA), which will be
available for use in other health centers.
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